Floatz logo

Anti-Thymoglobulin, Rabbit

Sickle Cell Anemia

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

135 Active assets in the Sickle Cell Anemia cohort.

Asset / SponsorPhaseRating
Glutamine
Ain Shams University
Phase 4BBB
Hydroxyurea
St. Jude Children's Research Hospital
Phase 4BB
Crizanlizumab
Novartis Pharmaceuticals
Phase 4BB
FILGRASTIM
St. Jude Children's Research Hospital
Phase 4BB
MAGNESIUM METALLICUM
Medical College of Wisconsin
Phase 3BB

View all 50 →

Same molecule, other indications

Anti-Thymoglobulin, Rabbit is also rated in:

myelodysplastic/myeloproliferative neoplasmDormant
BBB
Indicative ·
75 / 100
View asset →
plasma cell myelomaDormant
BBB
Indicative ·
72 / 100
View asset →
myeloproliferative neoplasmDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →